Related references
Note: Only part of the references are listed.Skeletal muscle anabolism is a side effect of therapy with the MEK inhibitor: selumetinib in patients with cholangiocarcinoma
C. M. M. Prado et al.
BRITISH JOURNAL OF CANCER (2012)
Cancer Cachexia: Mediators, Signaling, and Metabolic Pathways
Kenneth C. H. Fearon et al.
CELL METABOLISM (2012)
Sexual dimorphism modulates the impact of cancer cachexia on lower limb muscle mass and function
Nathan A. Stephens et al.
CLINICAL NUTRITION (2012)
Marked changes in body composition following neoadjuvant chemotherapy for oesophagogastric cancer
Sherif Awad et al.
CLINICAL NUTRITION (2012)
Clinical Experience with Thalidomide and Lenalidomide in Multiple Myeloma
T. Moehler
CURRENT CANCER DRUG TARGETS (2012)
P-selectin genotype is associated with the development of cancer cachexia
Benjamin H. L. Tan et al.
EMBO MOLECULAR MEDICINE (2012)
Physical Activity Monitoring: A Responsive and Meaningful Patient-Centered Outcome for Surgery, Chemotherapy, or Radiotherapy?
Eduardo Ferriolli et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2012)
Oral Nutritional Interventions in Malnourished Patients With Cancer: A Systematic Review and Meta-Analysis
Christine Baldwin et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Aberrations in Plasma Phospholipid Fatty Acids in Lung Cancer Patients
Rachel A. Murphy et al.
LIPIDS (2012)
Sarcopenia Predicts Early Dose-Limiting Toxicities and Pharmacokinetics of Sorafenib in Patients with Hepatocellular Carcinoma
Olivier Mir et al.
PLOS ONE (2012)
Are there any benefits of exercise training in cancer cachexia?
Josep M. Argiles et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2012)
Muscle Wasting in Cancer Cachexia: Clinical Implications, Diagnosis, and Emerging Treatment Strategies
Shontelle Dodson et al.
ANNUAL REVIEW OF MEDICINE, VOL 62, 2011 (2011)
Supplementation With Fish Oil Increases First-Line Chemotherapy Efficacy in Patients With Advanced Nonsmall Cell Lung Cancer
Rachel A. Murphy et al.
CANCER (2011)
Nutritional Intervention With Fish Oil Provides a Benefit Over Standard of Care for Weight and Skeletal Muscle Mass in Patients With Nonsmall Cell Lung Cancer Receiving Chemotherapy
Rachel A. Murphy et al.
CANCER (2011)
The Evolution of Adjuvant Therapy in the Treatment of Early-Stage Colon Cancer
Aimery de Gramont et al.
CLINICAL COLORECTAL CANCER (2011)
Would you buy a new tool to improve your practice?
Claude Pichard et al.
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2011)
Two faces of drug therapy in cancer: drug-related lean tissue loss and its adverse consequences to survival and toxicity
Carla M. M. Prado et al.
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2011)
A humanized anti-IL-6 antibody (ALD518) in non-small cell lung cancer
Trevor J. Bayliss et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2011)
Central nervous system inflammation induces muscle atrophy via activation of the hypothalamic-pituitary-adrenal axis
Theodore P. Braun et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Definition and classification of cancer cachexia: an international consensus
Kenneth Fearon et al.
LANCET ONCOLOGY (2011)
Physical Exercise for Cancer Patients with Advanced Disease: A Randomized Controlled Trial
Line M. Oldervoll et al.
ONCOLOGIST (2011)
Adipose Triglyceride Lipase Contributes to Cancer-Associated Cachexia
Suman K. Das et al.
SCIENCE (2011)
The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial
James T. Dalton et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2011)
Targeting the myostatin signaling pathway to treat muscle wasting diseases
H.Q. Han et al.
Current Opinion in Supportive and Palliative Care (2011)
Update on clinical trials of growth factors and anabolic steroids in cachexia and wasting
Norleena P. Gullett et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2010)
Acute inhibition of myostatin-family proteins preserves skeletal muscle in mouse models of cancer cachexia
Margaret E. Benny Klimek et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Reversal of Cancer Cachexia and Muscle Wasting by ActRIIB Antagonism Leads to Prolonged Survival
Xiaolan Zhou et al.
CELL (2010)
Prognostic Factors in Patients With Advanced Cancer: Use of the Patient-Generated Subjective Global Assessment in Survival Prediction
Lisa Martin et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Association of Skeletal Muscle Wasting With Treatment With Sorafenib in Patients With Advanced Renal Cell Carcinoma: Results From a Placebo-Controlled Study
Sami Antoun et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Energy regulation and neuroendocrine-immune control in chronic inflammatory diseases
R. H. Straub et al.
JOURNAL OF INTERNAL MEDICINE (2010)
Oral Nutritional Supplements Containing (n-3) Polyunsaturated Fatty Acids Affect the Nutritional Status of Patients with Stage III Non-Small Cell Lung Cancer during Multimodality Treatment
Barbara S. van der Meij et al.
JOURNAL OF NUTRITION (2010)
Developing Research Programs in Clinical and Translational Nutrition
Frederick A. Moore et al.
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION (2010)
Efficacy and Costs of Nutritional Rehabilitation in Muscle-Wasted Patients With Chronic Obstructive Pulmonary Disease in a Community-Based Setting: A Prespecified Subgroup Analysis of the INTERCOM Trial
Carel R. van Wetering et al.
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2010)
Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training
Karsten Lenk et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2010)
Chemotherapy and quality of life in NSCLC PS 2 patients
Nina Helbekkmo et al.
ACTA ONCOLOGICA (2009)
A viscerally driven cachexia syndrome in patients with advanced colorectal cancer: contributions of organ and tumor mass to whole-body energy demands
Jessica R. Lieffers et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2009)
Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size
Anne Ulrike Trendelenburg et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2009)
Sarcopenia in an Overweight or Obese Patient Is an Adverse Prognostic Factor in Pancreatic Cancer
Benjamin H. L. Tan et al.
CLINICAL CANCER RESEARCH (2009)
ESPEN Guidelines on Parenteral Nutrition: Non-surgical oncology
F. Bozzetti et al.
CLINICAL NUTRITION (2009)
Thalidomide inhibits lipopolysaccharide-induced tumor necrosis factor-α production via down-regulation of MyD88 expression
Abu Shadat M. Noman et al.
Innate Immunity (2009)
Chemotherapy is linked to severe vitamin D deficiency in patients with colorectal cancer
Marwan G. Fakih et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2009)
ASPEN Clinical Guidelines: Nutrition Support Therapy During Adult Anticancer Treatment and in Hematopoietic Cell Transplantation
David Allen August et al.
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION (2009)
Choline: an essential nutrient for public health
Steven H. Zeisel et al.
NUTRITION REVIEWS (2009)
Fighting Over Food: Patient and Family Understanding of Cancer Cachexia
Joanne Reid et al.
ONCOLOGY NURSING FORUM (2009)
Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study
Carla M. M. Prado et al.
LANCET ONCOLOGY (2008)
The opposing effects of n-3 and n-6 fatty acids
Gerd Schmitz et al.
PROGRESS IN LIPID RESEARCH (2008)
Proinflammatory cytokines and sickness behavior: Implications for depression and cancer-related symptoms
Jamie S. Myers
ONCOLOGY NURSING FORUM (2008)
Risk factor paradox in wasting diseases
Kamyar Kalantar-Zadeh et al.
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2007)
Cisplatin-versus carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: An individual patient data meta-analysis
Andrea Ardizzoni et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Insulin treatment in cancer cachexia:: Effects on survival, metabolism, and physical functioning
Kent Lundholm et al.
CLINICAL CANCER RESEARCH (2007)
Effect of 10 days of bed rest on skeletal muscle in healthy older adults
Patrick Kortebein et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Androgen therapy induces muscle protein anabolism in older women
Melinda Sheffield-Moore et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
The views and practice of oncologists towards nutritional support in patients receiving chemotherapy
A. Spiro et al.
BRITISH JOURNAL OF CANCER (2006)
Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: A multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the cannabis-in-cachexia-study-group
Florian Strasser et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
ESPEN guidelines on enteral nutrition:: Non-surgical oncology
J. Arends et al.
CLINICAL NUTRITION (2006)
Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial
JN Gordon et al.
GUT (2005)
Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids
AWG Moses et al.
BRITISH JOURNAL OF CANCER (2004)
CNTO 328, a monoclonal antibody to IL-6, inhibits human tumor-induced cachexia in nude mice
MH Zaki et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Ghrelin increases energy intake in cancer patients with impaired appetite: Acute, randomized, placebo-controlled trial
NM Neary et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers?
PJ Ross et al.
BRITISH JOURNAL OF CANCER (2004)
Palliative nutritional intervention in addition to cyclooxygenase and erythropoietin treatment for patients with malignant disease:: Effects on survival, metabolism, and function -: A randomized prospective study
K Lundholm et al.
CANCER (2004)
Effect of a protein and energy dense n-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial
KCH Fearon et al.
GUT (2003)
Oesophageal cancer and cachexia: the effect of short-term treatment with thalidomide on weight loss and lean body mass
ZH Khan et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
Changes in body composition during androgen deprivation therapy for prostate cancer
MR Smith et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo
SC Bodine et al.
NATURE CELL BIOLOGY (2001)
Nutritional support of the cancer patient: issues and dilemmas
G Nitenberg et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2000)
Share Paper
